MARIA LASCURAIN: Open Payments
NPI 1184012171 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 14 payments from 6 companies in 2025. Trend: 2023 $22 · 2024 $85 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $106 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| Boston Scientific Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: LEQVIO, CAMZYOS, Kerendia, General - Therapies, GEMTESA, WAINUA.
Industry payments across FL — which companies pay providers there.
